1. 31 MCPyV and the immune system: Target and modulator. Issue 5 (May 2015) Authors: Hadrup, S.R.; Schrama, D.; Ritter, C. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31 MCPyV and the immune system: Target and modulator. Issue 5 (May 2015) Authors: Becker, J.C.; Hadrup, S.R.; Schrama, D.; Ritter, C. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31 MCPyV and the immune system: Target and modulator. Issue 5 (May 2015) Authors: Becker, J.C.; Hadrup, S.R.; Schrama, D.; Ritter, C. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adaptation of Listeria monocytogenes in a simulated cheese medium: effects on virulence using the Galleria mellonella infection model. (25th March 2013) Authors: Schrama, D.; Helliwell, N.; Neto, L.; Faleiro, M.L. Journal: Letters in applied microbiology Issue: Volume 56:Number 6(2013:Jun.) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adcitmer®, a new CD56‐targeting monomethyl auristatin E‐conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. (1st February 2022) Authors: Esnault, C.; Leblond, V.; Martin, C.; Desgranges, A.; Baltus, C.B.; Aubrey, N.; Lakhrif, Z.; Lajoie, L.; Lantier, L.; Clémenceau, B.; Sarma, B.; Schrama, J.; Houben, R.; Schrama, D.; Hesbacher, S.; Gouilleux‐Gruart, V.; Feng, Y.; Dimitrov, D.; Guyétant, S.; Berthon, P. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adcitmer®, a new CD56‐targeting monomethyl auristatin E‐conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. (2nd November 2021) Authors: Esnault, C.; Leblond, V.; Martin, C.; Desgranges, A.; Baltus, C.B.; Aubrey, N.; Lakhrif, Z.; Lajoie, L.; Lantier, L.; Clémenceau, B.; Sarma, B.; Schrama, J.; Houben, R.; Schrama, D.; Hesbacher, S.; Gouilleux‐Gruart, V.; Feng, Y.; Dimitrov, D.; Guyétant, S.; Berthon, P. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. BerEP4 positivity in Merkel cell carcinoma: a potential diagnosis pitfall. (3rd August 2020) Authors: Kervarrec, T.; Tallegas, M.; Schrama, D.; Houben, R.; Ollier, J.; Clémenceau, B.; Vié, H.; Touzé, A.; Samimi, M.; Guyétant, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 11(2020) Page Start: e707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. BRAF mutation analysis of only one metastatic lesion can restrict the treatment of melanoma: a case report. (27th September 2012) Authors: Richtig, E.; Schrama, D.; Ugurel, S.; Fried, I.; Niederkorn, A.; Massone, C.; Becker, J.C. Journal: British journal of dermatology Issue: Volume 168:Number 2(2013:Feb.) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway. (1st March 2022) Authors: Maurus, K.; Kosnopfel, C.; Kneitz, H.; Appenzeller, S.; Schrama, D.; Glutsch, V.; Roth, S.; Gerhard‐Hartmann, E.; Rosenfeldt, M.; Möhrmann, L.; Fröhlich, M.; Hübschmann, D.; Stenzinger, A.; Glimm, H.; Fröhling, S.; Goebeler, M.; Rosenwald, A.; Kutzner, H.; Schilling, B. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway. (21st December 2021) Authors: Maurus, K.; Kosnopfel, C.; Kneitz, H.; Appenzeller, S.; Schrama, D.; Glutsch, V.; Roth, S.; Gerhard‐Hartmann, E.; Rosenfeldt, M.; Möhrmann, L.; Fröhlich, M.; Hübschmann, D.; Stenzinger, A.; Glimm, H.; Fröhling, S.; Goebeler, M.; Rosenwald, A.; Kutzner, H.; Schilling, B. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗